| UniProt ID | AN13A_HUMAN | |
|---|---|---|
| UniProt AC | Q8IZ07 | |
| Protein Name | Ankyrin repeat domain-containing protein 13A | |
| Gene Name | ANKRD13A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 590 | |
| Subcellular Localization | Cell membrane . Late endosome . Interaction with EGFR may enhance association with the cell membrane. | |
| Protein Description | Ubiquitin-binding protein that specifically recognizes and binds 'Lys-63'-linked ubiquitin. Does not bind 'Lys-48'-linked ubiquitin. Positively regulates the internalization of ligand-activated EGFR by binding to the Ub moiety of ubiquitinated EGFR at the cell membrane.. | |
| Protein Sequence | MSSACDAGDHYPLHLLVWKNDYRQLEKELQGQNVEAVDPRGRTLLHLAVSLGHLESARVLLRHKADVTKENRQGWTVLHEAVSTGDPEMVYTVLQHRDYHNTSMALEGVPELLQKILEAPDFYVQMKWEFTSWVPLVSRICPNDVCRIWKSGAKLRVDITLLGFENMSWIRGRRSFIFKGEDNWAELMEVNHDDKVVTTERFDLSQEMERLTLDLMKPKSREVERRLTSPVINTSLDTKNIAFERTKSGFWGWRTDKAEVVNGYEAKVYTVNNVNVITKIRTEHLTEEEKKRYKADRNPLESLLGTVEHQFGAQGDLTTECATANNPTAITPDEYFNEEFDLKDRDIGRPKELTIRTQKFKAMLWMCEEFPLSLVEQVIPIIDLMARTSAHFARLRDFIKLEFPPGFPVKIEIPLFHVLNARITFGNVNGCSTAEESVSQNVEGTQADSASHITNFEVDQSVFEIPESYYVQDNGRNVHLQDEDYEIMQFAIQQSLLESSRSQELSGPASNGGISQTNTYDAQYERAIQESLLTSTEGLCPSALSETSRFDNDLQLAMELSAKELEEWELRLQEEEAELQQVLQLSLTDK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSSACDAGD ------CCCCCCCCC | 27.00 | 28857561 | |
| 3 | Phosphorylation | -----MSSACDAGDH -----CCCCCCCCCC | 31.45 | 28857561 | |
| 19 | Ubiquitination | PLHLLVWKNDYRQLE CEEEEEEECHHHHHH | 32.25 | 21890473 | |
| 27 | Ubiquitination | NDYRQLEKELQGQNV CHHHHHHHHHCCCCC | 72.77 | 21906983 | |
| 91 | Phosphorylation | TGDPEMVYTVLQHRD CCCHHHHEEEEHHCC | 6.99 | 75317 | |
| 99 | Phosphorylation | TVLQHRDYHNTSMAL EEEHHCCCCCHHHHH | 9.27 | 22199227 | |
| 102 | Phosphorylation | QHRDYHNTSMALEGV HHCCCCCHHHHHCCH | 13.43 | 28857561 | |
| 103 | Phosphorylation | HRDYHNTSMALEGVP HCCCCCHHHHHCCHH | 13.84 | 22199227 | |
| 175 | Phosphorylation | SWIRGRRSFIFKGED CEECCCCEEEEECCC | 22.72 | 24719451 | |
| 188 | Sulfoxidation | EDNWAELMEVNHDDK CCCHHHHCCCCCCCC | 3.98 | 30846556 | |
| 195 | Ubiquitination | MEVNHDDKVVTTERF CCCCCCCCEEEECCC | 44.66 | 21906983 | |
| 205 | Phosphorylation | TTERFDLSQEMERLT EECCCCHHHHHHHHH | 26.41 | 21082442 | |
| 208 | Sulfoxidation | RFDLSQEMERLTLDL CCCHHHHHHHHHHHH | 2.55 | 21406390 | |
| 217 | Ubiquitination | RLTLDLMKPKSREVE HHHHHHHCCCCHHHH | 57.50 | 21906983 | |
| 217 | Acetylation | RLTLDLMKPKSREVE HHHHHHHCCCCHHHH | 57.50 | 7825331 | |
| 219 | Ubiquitination | TLDLMKPKSREVERR HHHHHCCCCHHHHHH | 57.54 | - | |
| 219 | Acetylation | TLDLMKPKSREVERR HHHHHCCCCHHHHHH | 57.54 | 7825341 | |
| 228 | Phosphorylation | REVERRLTSPVINTS HHHHHHHCCCCCCCC | 29.22 | 28857561 | |
| 229 | Phosphorylation | EVERRLTSPVINTSL HHHHHHCCCCCCCCC | 23.05 | 28857561 | |
| 239 | Ubiquitination | INTSLDTKNIAFERT CCCCCCCCCCEEEEC | 46.13 | 21906983 | |
| 247 | Ubiquitination | NIAFERTKSGFWGWR CCEEEECCCCCCCEE | 55.60 | 21906983 | |
| 248 | Phosphorylation | IAFERTKSGFWGWRT CEEEECCCCCCCEEC | 38.31 | 28857561 | |
| 257 | Ubiquitination | FWGWRTDKAEVVNGY CCCEECCCEEEECCE | 45.92 | 21906983 | |
| 269 | Phosphorylation | NGYEAKVYTVNNVNV CCEEEEEEEECCEEE | 12.31 | 28064214 | |
| 270 | Phosphorylation | GYEAKVYTVNNVNVI CEEEEEEEECCEEEE | 21.53 | 30301811 | |
| 279 | Ubiquitination | NNVNVITKIRTEHLT CCEEEEEEEEHHHCC | 21.04 | 21906983 | |
| 281 | Methylation | VNVITKIRTEHLTEE EEEEEEEEHHHCCHH | 35.30 | - | |
| 290 | Ubiquitination | EHLTEEEKKRYKADR HHCCHHHHHHHHCCC | 45.92 | - | |
| 291 | Ubiquitination | HLTEEEKKRYKADRN HCCHHHHHHHHCCCC | 65.33 | - | |
| 351 | Ubiquitination | DRDIGRPKELTIRTQ CCCCCCCCCCEEHHH | 65.09 | - | |
| 400 | Ubiquitination | ARLRDFIKLEFPPGF HHHHHHHCCCCCCCC | 41.79 | 21906983 | |
| 410 | Ubiquitination | FPPGFPVKIEIPLFH CCCCCCEEEEEEEEE | 34.55 | 21906983 | |
| 470 | Phosphorylation | FEIPESYYVQDNGRN EECCCCEEEEECCEE | 10.83 | 22817900 | |
| 485 | Phosphorylation | VHLQDEDYEIMQFAI EEECCCCHHHHHHHH | 12.81 | 119633 | |
| 506 | Phosphorylation | SSRSQELSGPASNGG HCCCCCCCCCCCCCC | 41.81 | 28857561 | |
| 510 | Phosphorylation | QELSGPASNGGISQT CCCCCCCCCCCCCCC | 38.86 | 113326403 | |
| 515 | Phosphorylation | PASNGGISQTNTYDA CCCCCCCCCCCCHHH | 33.94 | 28555341 | |
| 519 | Phosphorylation | GGISQTNTYDAQYER CCCCCCCCHHHHHHH | 26.60 | 21552520 | |
| 520 | Phosphorylation | GISQTNTYDAQYERA CCCCCCCHHHHHHHH | 16.02 | 22817900 | |
| 524 | Phosphorylation | TNTYDAQYERAIQES CCCHHHHHHHHHHHH | 14.76 | 22817900 | |
| 534 | Phosphorylation | AIQESLLTSTEGLCP HHHHHHHHCCCCCCH | 38.61 | 28857561 | |
| 535 | Phosphorylation | IQESLLTSTEGLCPS HHHHHHHCCCCCCHH | 25.16 | 28857561 | |
| 536 | Phosphorylation | QESLLTSTEGLCPSA HHHHHHCCCCCCHHH | 28.92 | 28857561 | |
| 563 | Ubiquitination | LAMELSAKELEEWEL HHHHHCHHHHHHHHH | 60.50 | 21906983 | |
| 586 | Phosphorylation | LQQVLQLSLTDK--- HHHHHHHHHCCC--- | 19.09 | 22298428 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AN13A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AN13A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| UBC_HUMAN | UBC | physical | 22298428 | |
| TERA_HUMAN | VCP | physical | 26797118 | |
| CAV1_HUMAN | CAV1 | physical | 26797118 | |
| GDIR1_HUMAN | ARHGDIA | physical | 27173435 | |
| STOM_HUMAN | STOM | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...